Landos Biopharma, Inc. (LABP) Tops Q2 EPS by 44c

Landos Biopharma, Inc. (NASDAQ: LABP) reported Q2 EPS of ($0.63), $0.44 better than the analyst estimate of ($1.07).

For earnings history and earnings-related data on Landos Biopharma, Inc. (LABP) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Eledon Pharmaceuticals, Inc. (ELDN) Misses Q2 EPS by 12c
• Hitachi Ltd. (HIT) Misses Q2 EPS by 7c